PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases Feb 29, 2024
Mad2 expression levels with chromosomal abnormalities can be a biomarker for esophageal cancer Feb 13, 2024